MILLER RICHARD A MD 4
4 · Corvus Pharmaceuticals, Inc. · Filed Dec 15, 2022
Insider Transaction Report
Form 4
MILLER RICHARD A MD
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-12-14$0.78/sh+10,000$7,812→ 1,490,119 total(indirect: By Trust) - Purchase
Common Stock
2022-12-13$0.74/sh+50,000$37,015→ 1,480,119 total(indirect: By Trust)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.73 to $0.7580, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 35,714 shares previously held directly.
- [F3]These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
- [F4]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7798 to $0.7899, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.